Jet Capital Investors L P Point Biopharma Global Inc. Put Options Transaction History

Jet Capital Investors L P

  • $0
  • Q3 2024

Put Options

1 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$6.68 - $14.23 $18,704 - $39,844
2,800 New
2,800 $35,000

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0
View Full List

About POINT Biopharma Global Inc.

PNT Quotes by TradingView
  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Jet Capital Investors L P Portfolio

Follow Jet Capital Investors L P and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jet Capital Investors L P, based on Form 13F filings with the SEC.

News

Stay updated on Jet Capital Investors L P with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email